The presence of resistance mutations to protease and polymerase inhibitors in Hepatitis C virus sequences from the Los Alamos databank-Reference-Cited by-同舟云学术

The presence of resistance mutations to protease and polymerase inhibitors in Hepatitis C virus sequences from the Los Alamos databank

Published:2013-02-06 Issue:6 Volume:20 Page:414-421
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Alves R.¹,Queiroz A. T. L.²,Pessoa M. G.³,da Silva E. F.³,Mazo D. F. C.³,Carrilho F. J.³,Carvalho-Filho R. J.¹,de Carvalho I. M. V. G.¹⁴

Affiliation:

1. Laboratório de Hepatologia Molecular Aplicada; Setor de Hepatites; Divisão de Gastroenterologia; Universidade Federal de São Paulo; Sao Paulo Brazil

2. Laboratório de Imunoparasitologia; CPqGM - FIOCRUZ; Salvador Brazil

3. Department of Gastroenterology; University of Sao Paulo School of Medicine; Sao Paulo Brazil

4. Imunologia Viral; Instituto Butantan; Sao Paulo Brazil

Funder

Fundação de Amparo a Pesquisa do Estado de São Paulo

Capes/Escola de Altos Estudos

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12051/fullpdf

Reference53 articles.

1. Evolving epidemiology of hepatitis C virus;Lavanchy;Clin Microbiol Infect,2011

2. Moving beyond interferon alfa: investigational drugs for hepatitis C virus infection;Wyles;Top HIV Med,2010

3. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

4. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

5. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Resistance-Associated Substitutions Among People Who Inject Drugs Treated With Direct-Acting Antiviral-Containing Regimens;Open Forum Infectious Diseases;2021-09-30

2. Discovery of Novel HCV NS5B polymerase inhibitor, 2‐(3,4‐dimethyl‐5,5‐dioxidobenzo[ e ]pyrazolo[4,3‐ c ][1,2]thiazin‐2(4 H )‐yl)‐ N ‐(2‐fluorobenzyl)acetamide via molecular docking and experimental approach;Clinical and Experimental Pharmacology and Physiology;2021-09-06

3. World-wide Prevalence of Substitutions in HCV Genome Associated With Resistance to Direct-Acting Antiviral Agents;Clinical Gastroenterology and Hepatology;2021-09

4. Analysis of drug-resistance-associated mutations and genetic barriers in hepatitis C virus NS5B sequences in China;Archives of Virology;2020-06-29

5. Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population;Clinics and Research in Hepatology and Gastroenterology;2019-10